$4.8bn US for x 4 indications in 2591
+ % for upside in other potential indications given x 4 are successful and 2566 already commercial in x 1 and 2nd phase 2.
+ $2bn US minimum for 2566 licensing agreement in place, suitor picks this future cash flow up. (our 20% share + milestones)
= $7-$8bn US valuation minimum for Neu based on this tool, approx in AUD $10.6bn - $12.2bn
Merck to acquire Prometheus in a US$ 10.8 b deal, page-10
-
- There are more pages in this discussion • 99 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$15.27 |
Change
0.920(6.41%) |
Mkt cap ! $1.951B | |||
| Open | High | Low | Value | Volume |
| $14.35 | $15.27 | $14.35 | $8.720M | 579.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 1000 | $15.25 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $15.27 | 3638 | 4 |
View Market Depth
| Last trade - 16.10pm 27/09/2024 (20 minute delay) ? |
| NEU (ASX) Chart |